-
公开(公告)号:US11561178B2
公开(公告)日:2023-01-24
申请号:US17301975
申请日:2021-04-20
申请人: Tempus Labs, Inc.
发明人: Madhavi Kannan , Brian Larsen , Aly A. Khan , Ameen Salahudeen
IPC分类号: G01N21/64 , G01N33/50 , G02B21/12 , G02B21/00 , G01N21/552 , G06T7/00 , G06N20/00 , G16H30/00 , G06V20/69
摘要: The disclosure provides a method of generating an artificial fluorescent image of cells is provided. The method includes receiving a brightfield image generated by a brightfield microscopy imaging modality of at least a portion of cells included in a specimen, applying, to the brightfield image, at least one trained model, the trained model being trained to generate the artificial fluorescent image based on the brightfield image, receiving the artificial fluorescent image from the trained model
-
公开(公告)号:US11527323B2
公开(公告)日:2022-12-13
申请号:US15930234
申请日:2020-05-12
申请人: Tempus Labs, Inc.
发明人: Jackson Michuda , Kyle Ashley Beauchamp , Joshuah Kapilivsky , Calvin McCarter , Nike Beaubier , Martin Christian Stumpe , Catherine Igartua , Joshua S K Bell , Timothy Taxter , Raphael Pelossof
摘要: Systems and methods are provided for identifying a diagnosis of a cancer condition for a somatic tumor specimen of a subject. The method receives sequencing information comprising analysis of a plurality of nucleic acids derived from the somatic tumor specimen. The method identifies a plurality of features from the sequencing information, including two or more of RNA, DNA, RNA splicing, viral, and copy number features. The method provides a first subset of features and a second subset of features from the identified plurality of features as inputs to a first classifier and a second classifier, respectively. The method generates, from two or more classifiers, two or more predictions of cancer condition based at least in part on the identified plurality of features. The method combines, at a final classifier, the two or more predictions to identify the diagnosis of the cancer condition for the somatic tumor specimen of the subject.
-
公开(公告)号:US20220392640A1
公开(公告)日:2022-12-08
申请号:US17771401
申请日:2020-10-22
申请人: Tempus Labs, Inc.
发明人: Ameen Salahudeen , Brian M. Larsen , Michelle M. Stein , Luka A. Karginov , Madhavi Kannan , Aly A. Khan , Verónica Sánchez Freire , Yilin Zhang
摘要: Methods, systems, and software are provided for using organoid cultures, e.g., patient-derived tumor organoid cultures, to improve treatment predictions and outcomes.
-
公开(公告)号:US20220384045A1
公开(公告)日:2022-12-01
申请号:US17829357
申请日:2022-05-31
申请人: Tempus Labs, Inc.
发明人: Noah Zimmerman
摘要: A method and system for predicting the likelihood that a patient will suffer from a cardiac event is provided. The method includes receiving electrocardiogram data associated with the patient, providing at least a portion of the electrocardiogram data to a trained model, receiving a risk score indicative of the likelihood the patient will suffer from the cardiac event within a predetermined period of time from when the electrocardiogram data was generated, and outputting the risk score to at least one of a memory or a display for viewing by a medical practitioner or healthcare administrator. The system includes at least one processor executing instructions to carry out the steps of the method.
-
公开(公告)号:US20220367006A1
公开(公告)日:2022-11-17
申请号:US17858872
申请日:2022-07-06
申请人: Tempus Labs, Inc.
发明人: Robert Tell , Wei Zhu , Justin David Finkle , Christine Lo , Terri M. Driessen
摘要: Methods, systems, and software are provided for validating a somatic sequence variant in a subject having a cancer condition. Sequence reads are obtained from sequencing cell-free DNA fragments in a liquid biopsy sample of the subject. Sequence reads are aligned to a reference sequence. A variant allele fragment count and locus fragment count are identified for a candidate variant that maps to a locus in the reference sequence. The variant allele fragment count is compared against a dynamic variant count threshold for the locus. The threshold is based on a pre-test odds of a positive variant call for the locus, based on the prevalence of variants in a genomic region including the locus in a cohort of subjects having the cancer condition. The somatic sequence variant in the subject is validated, or rejected, when the variant allele fragment count for the candidate variant satisfies, or does not satisfy, the threshold.
-
公开(公告)号:US20220293218A1
公开(公告)日:2022-09-15
申请号:US17829228
申请日:2022-05-31
申请人: TEMPUS LABS, INC.
发明人: Stephen Yip , Irvin Ho , Lingdao Sha , Boleslaw Osinski , Aly Azeem Khan , Andrew J. Kruger , Michael Carlson , Abel Greenwald , Caleb Willis , Andrew Westley , Ryan Jones , Brett Mahon
IPC分类号: G16B30/00 , G16B50/30 , C12Q1/6869
摘要: A method for qualifying a specimen prepared on one or more hematoxylin and eosin (H&E) slides by assessing an expected yield of nucleic acids for tumor cells and providing associated unstained slides for subsequent nucleic acid analysis is provided.
-
17.
公开(公告)号:US20220189600A1
公开(公告)日:2022-06-16
申请号:US17686396
申请日:2022-03-03
申请人: Tempus Labs, Inc.
发明人: Mathew Barber , Ryan Mork
IPC分类号: G16H20/10 , G16H10/60 , G06N20/00 , G16H50/30 , G06V30/413
摘要: In one aspect, the present disclosure provides a method for labeling one or more medications concurrently administered to a patient as a line of therapy. The method includes identifying medical records of the patient from a plurality of digital records, creating, from the subset of medical records, a plurality of treatment intervals including at least one medication administered to the patient and a time interval, associating medications of the one or more treatments with a respective treatment interval when the administration of the medication falls within the time interval, refining the time interval of a respective treatment interval when a treatment of the one or more treatments falls outside the time interval but within an extension period, identifying one or more potential lines of therapy from the plurality of treatment intervals, and labeling the potential line of therapy having the highest maximum likelihood estimation as the line of therapy.
-
公开(公告)号:US20220148736A1
公开(公告)日:2022-05-12
申请号:US17558479
申请日:2021-12-21
申请人: Tempus Labs, Inc.
发明人: Ashraf Hafez , Martin Christian Stumpe , Nike Beaubier , Daniel Neems , Caroline Epstein , Adrian William George Lange
摘要: Systems and methods are provided for predicting metastasis of a cancer in a subject. A plurality of data elements for the subject's cancer is obtained, including sequence features comprising relative abundance values for gene expression in a cancer biopsy of the subject, optional personal characteristics about the subject, and optional clinical features related to the stage, histopathological grade, diagnosis, symptom, comorbidity, and/or treatment of the cancer in the subject, and/or a temporal element associated therewith. One or more models are applied to the plurality of data elements, determining one or more indications of whether the cancer will metastasize. A clinical report comprising the one or more indications is generated.
-
公开(公告)号:US20220059190A1
公开(公告)日:2022-02-24
申请号:US17405025
申请日:2021-08-18
申请人: Tempus Labs, Inc.
发明人: Talal Ahmed , Raphael Pelossof , Stephane Wenric , Mark Carty
摘要: A method for transferring a dataset-specific nature of a first dataset with sequencing results for a first plurality of specimen to a second dataset with sequencing results for a second plurality of specimen includes receiving a first set of adaptation factors of the first dataset that include two or more eigenvectors, where the sequencing cannot be reconstructed from the first set of adaptation factors without access to the first dataset. The method also includes generating a second set of adaptation factors of the second dataset that include two or more eigenvectors of the second dataset. The method also includes generating an adapted second dataset by adapting the dataset-specific nature of the second dataset to the dataset-specific nature of the second dataset based at least in part on the first and second sets of adaptation factors, and providing the adapted second dataset to the first entity.
-
公开(公告)号:US20210358571A1
公开(公告)日:2021-11-18
申请号:US17302867
申请日:2021-05-13
申请人: Tempus Labs, Inc.
发明人: Sumaiya Islam , Robert Huether
摘要: A method of categorizing fusions is provided by the present disclosure. The method includes receiving labeled fusion data including at least one of DNA data or RNA data including at least one detected fusion associated with a specimen, providing the labeled fusion data to a classifier trained to generate a pathogenicity metric corresponding to pathogenicity of each detected fusion, receiving at least one pathogenicity metric from the classifier, and generating a report including one or more detected fusions included in the at least one detected fusion based on the pathogenicity metrics.
-
-
-
-
-
-
-
-
-